This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Coca-Cola (KO) Chalks Out Plan for Coffee Business, Cannabis
by Zacks Equity Research
Coca-Cola (KO) reveals strategy for the newly acquired coffee chain Costa, and also puts forward plans for growth in the cannabis space.
FEMSA (FMX) Earnings Miss, Revenues Beat Estimates in Q3
by Zacks Equity Research
FEMSA (FMX) misses earnings estimates for third-quarter 2018 mainly due to gains from the sale of stakes in Heineken in the year-ago quarter. Further, currency headwinds hurt results.
Here's What Investors Must Know About FEMSA (FMX) Stock
by Zacks Equity Research
FEMSA's (FMX) strategic initiatives like store expansion, portfolio diversification and focus on core business position it for long-term growth. However, soft margins and higher costs remain hurdles.
Molson Coors and HEXO Joint Venture Goes Live as "Truss"
by Zacks Equity Research
Molson Coors Canada (TAP) and Hydropothecary launch its JV, Truss, to explore the non-alcoholic cannabis-infused drinks market, just before cannabis trade is legalized in Canada.
After Coke, It's PepsiCo's Turn to Monitor Cannabis Market
by Zacks Equity Research
The cannabis-infused beverages industry is growing fast, attracting the attention of food and beverage giants.
Can Molson Coors Survive on Strategies as Beer Loses Fizz?
by Zacks Equity Research
Molson Coors (TAP) looks attractive, based on its focus on cost savings and premiumization as well as exposure to the marijuana space. But, overall softness in the beer industry weighs on the stock.
Top Wall Street Stories of the Third Quarter
by Sweta Killa
We discuss some of the events that dominated the headlines in the third quarter and influenced the market.
SAM Vs. TAP: Which Stock is Better Placed as Beer Loses Fizz?
by Zacks Equity Research
Beer space suffers due to soft beer sales, thanks to consumers shift to healthier options. However, players with diversified portfolio stand to gain. Let's see which a better stock in this space is.
Know How Beverage Stocks Will Gain From Shift to Marijuana
by Rajani Lohia
Cannabis-infused drinks have emerged as an attractive alternative to the problems of the players in the U.S. beverage space, given the health benefits it offers.
Coke Eyes Cannabis-Infused Beverages, Will Others Follow?
by Zacks Equity Research
Infused-drinks could emerge as the next big thing in the beverage market, attracting the focus of many big players.
Is Coca-Cola's Cannabis Venture a Solution to Its Problems?
by Zacks Equity Research
Coca-Cola (KO) explores the cannabis-infused drinks market to combat the fading popularity of sugary carbonated sodas.
ETFs & Stocks to Tap Marijuana Boom
by Sweta Killa
Investors seeking to tap the ongoing green rush may consider these ETFs and stocks.
What Investors Need to Know About Investing In Marijuana Stocks
by Benjamin Rains
Marijuana has come a long way since California legalized cannabis for medicinal use back in 1996. Today, the industry and marijuana look to be on the cusp of unprecedented acceptance, with major international giants investing billions into publicly traded cannabis companies. So let's take a look at what investors need to know about the marijuana industry and how to invest in the future of pot.
Zacks Industry Outlook Highlights: Anheuser-Busch, Constellation, Canopy Growth and Brown-Forman.
by Zacks Equity Research
Zacks Industry Outlook Highlights: Anheuser-Busch, Constellation, Canopy Growth and Brown-Forman.
Alcohol Outlook: Soft Beer Demand & High Costs to Hurt
by Zacks Equity Research
The Beverages - Alcohol industry is in the doldrums due to softness in the beer segment, the consumers' shift to healthy options and higher aluminum costs, which is hurting investors' confidence.
Constellation Brands Invests in Cannabis, Expands Canopy Stake
by Zacks Equity Research
Constellation Brands (STZ) expands its stake in Canada's Canopy Growth Corporation to 38% through an additional $5-billion investment.
FEMSA (FMX) on Crossroads: Can Strategies Counter Hurdles?
by Zacks Equity Research
FEMSA's (FMX) dismal earnings and sales surprise trend has been hurting the stock's performance. However, its strategic initiatives bode well.
Boston Beer (SAM) Q1 Earnings & Sales Beat, 2018 View Intact
by Zacks Equity Research
Boston Beer's (SAM) earnings and sales top estimates in first-quarter 2018, backed by improved shipments and depletions as well as higher gross margin. The company reiterates earnings view for 2018.
Here's What Makes FEMSA (FMX) a Good Investment Choice Now
by Zacks Equity Research
FEMSA (FMX) displays a solid momentum, backed by strategic initiatives. However, near-term headwinds related to soft top- and bottom-line results and strained margins cannot be ignored.
What's Hurting AB InBev (BUD) Stock Price After a Solid Q4?
by Zacks Equity Research
While AB InBev's (BUD) fourth-quarter 2017 results marked a return to the positive earnings trajectory, a soft outlook for the first quarter seems to be weighing upon its performance.
Here's Why Boston Beer (SAM) Rallies Despite a Dismal Q4
by Zacks Equity Research
While Boston Beer (SAM) fails to impress investors in the fourth quarter, its cost-saving plans and long-term innovation alongside the focus on reviving its brands keep the stock ticking.
Is the Dismal Surprise Trend a Grave Concern for FEMSA (FMX)?
by Zacks Equity Research
FEMSA (FMX) is losing momentum on grounds of dismal surprise history. However, its focus on strategic initiatives can help it steer through the storm.
FEMSA (FMX) Lags Q4 Earnings & Sales Estimates, Stock Falls
by Zacks Equity Research
Fomento Economico Mexicano S.A.B. de C.V. (FMX), alias FEMSA, reported lower-than-expected results for fourth-quarter 2017 with both the top and the bottom lines lagging estimates.
Can FEMSA (FMX) Sustain Recent Momentum in Q4 & in 2018?
by Zacks Equity Research
Fomento Economico Mexicano, S.A.B. de C.V. (FMX), alias FEMSA, has regained its position in investors' books after a solid third-quarter 2017, which marked a turnaround in the company's dismal surprise trend.
Will FEMSA's (FMX) Upside on Sturdy Q3 Earnings Sustain?
by Zacks Equity Research
Fomento Economico Mexicano S.A.B. de C.V. (FMX), alias FEMSA, has been witnessing significant surge since reporting a robust third-quarter 2017 that marked a turnaround in the company's dismal earnings trend over the past few quarters.